Bladder discomfort and tiropramide

Effect of tiroprimide on postoperative catheter-related bladder discomfort

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0005248

Enrollment

Registered

2020-07-22

Start date

2020-08-10

Completion date

Unknown

Last updated

2020-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : In control group, normal saline 1 ml will be infused. In experimental group, tiropramide 50 mg will be infused.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients with bladder discomfort due to postoperative urinary catheter insertion and consent to the investigation 2. Patients with American Society of Anesthesiologists physical status classification system I-III

Exclusion criteria

Exclusion criteria: 1. Pregnant patients 2. Patients with urinary tract obstruction 3, Patients with overactive or neurogenic bladder 4. Patients with body mass index > 35 kg/m2 5. Patients with analgesics due to chronic pain 6. Patients with allergy to tiropramide 7. Patients with seizure 8. Patients with gastrointestinal obstruction 9. Patients with shock 10. Patients with glaucoma

Design outcomes

Primary

Measure	Time frame
Bladder discomfort score at 20 min after study drug infusion	—

Secondary

Measure	Time frame
Bladder discomfort score at 0 min and 6 hour after study drug infusion;Nausea;Mouth dryness;Blurred vision;Dizziness;Constipation;Analgesics	—

Countries

Korea, Republic of

Contacts

Public ContactHyun-Chang Kim

Korea University Anam Hospital

Outcome results